Related Experiment Video
Updated: Dec 23, 2025

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Non-Invasive MRI of Blood-Cerebrospinal Fluid Barrier Function.
P G Evans1, M Sokolska2, A Alves3
1UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
A new non-invasive MRI method quantifies blood-cerebrospinal fluid barrier (BCSFB) function. This technique reveals significant BCSFB decline in aging and offers a novel target for neurodegenerative disease diagnostics and therapeutics.
Area of Science:
- Neuroscience
- Medical Imaging
- Physiology
Background:
- The blood-cerebrospinal fluid barrier (BCSFB) is crucial for brain homeostasis.
- Assessing BCSFB function non-invasively has been a significant challenge.
- Understanding BCSFB's role in brain development and pathology requires functional assessment tools.
Purpose of the Study:
- To develop and validate a non-invasive magnetic resonance imaging (MRI) method for quantifying BCSFB function.
- To assess BCSFB function changes in aged mice and compare it with parenchymal blood flow.
- To explore the relationship between BCSFB function and ventricular morphology, and demonstrate human brain applicability.
Main Methods:
- Development of a tracer-free MRI technique to measure water delivery rates from blood to cerebrospinal fluid.
- Application of the MRI method in aged mice to quantify BCSFB function.
- Correlation analysis between BCSFB function, parenchymal blood flow, and ventricular morphology.
Main Results:
- A novel non-invasive MRI method was established for BCSFB functional assessment.
- A 36% decrease in BCSFB function was observed in aged mice.
- The study demonstrated the method's applicability to the human brain, highlighting BCSFB as a potential diagnostic target.
Conclusions:
- The developed non-invasive MRI technique allows for safe and accurate quantification of BCSFB function.
- BCSFB function significantly declines with age, presenting a potential biomarker for neurodegenerative processes.
- The BCSFB is identified as a promising new target for diagnostics and therapeutics in neurological disorders.
More Related Videos
12:19An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
Published on: March 11, 2018
09:58A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016